Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NCOA4P2 is a pseudogene related to the nuclear receptor coactivator 4 (NCOA4) gene. Pseudogenes are DNA sequences similar to normal genes but are typically non-functional; they do not encode a functional protein and generally lack biological activity. While the parent gene NCOA4 functions as a nuclear receptor coactivator for several nuclear hormone receptors and has roles in processes like cell division, DNA replication, and cancer progression[1][3], NCOA4P2 itself does not encode a functional protein product and is not considered a druggable or therapeutic target. There are no known biological, pathological, or pharmacological functions associated with NCOA4P2, and it is not used as a biomarker or as a target for any approved or experimental drugs[5]. The abbreviation "NCOA4P2" correctly refers to this pseudogene, but it should not be confused with the functional NCOA4 gene or its protein products. Note: - The "P" in the name indicates "pseudogene." - NCOA4P2 is sometimes referenced in genomic databases, but is not a target for pharmacological intervention and has no known involvement in disease processes or biological pathways. - If you are seeking information about the functional coactivator (NCOA4), please specify, as it is a distinct entity with established roles in nuclear receptor signaling and cell biology[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear receptor coactivator 4 pseudogene 2 (NCOA4P2).